Search results
Results from the WOW.Com Content Network
Cinnarizine is an antihistamine and calcium channel blocker of the diphenylmethylpiperazine group. [5] It is prescribed for nausea and vomiting due to motion sickness [6] or other sources such as chemotherapy, [7] vertigo, [8] or Ménière's disease. [9] Cinnarizine is one of the leading causes of drug-induced parkinsonism. [5]
Countries have different recommendations concerning the administration of alcohol to minors by adults. United Kingdom: An alcohol-free childhood is the healthiest option. [54] Children aged under 15 should never be given alcohol, even in small quantities. Children aged 15–17 should not be given alcohol on more than one day a week – and then ...
"Treatment of vertigo due to acute unilateral vestibular loss with a fixed combination of cinnarizine and dimenhydrinate: a double-blind, randomized, parallel-group clinical study". Clin Ther . 26 (6): 866– 77.
Alcoholism: Clinical and Experimental Research is a scientific journal covering research concerning alcohol abuse and its treatment. It is published by Wiley-Blackwell on behalf of the Research Society on Alcoholism and the International Society for Biomedical Research on Alcoholism.
The model is most accurate when used to estimate BAC a few hours after drinking a single dose of alcohol in a fasted state, and can be within 20% CV of the true value. [ 121 ] [ 122 ] It is less accurate for BAC levels below 0.2 g/L (alcohol is not eliminated as quickly as predicted) and consumption with food (overestimating the peak BAC and ...
Alcohol dependence refers to an entity in which only alcohol is the involved addictive agent. Alcoholism refers to an entity in which alcohol or any cross-tolerant addictive agent is involved. In alcohol dependence, reduction of alcohol, as defined within DSM-IV, can be attained by learning to control the use of alcohol.
The Center of Alcohol Studies (CAS) is a multidisciplinary research institute located in the Busch Campus of Rutgers University, which performs clinical and biomedical research on alcohol use and misuse. The center was originally at Yale University and known as the Yale Center of Alcohol Studies, before it moved to Rutgers in 1962. [1]
Owing to the new finding of drug and alcohol abuse treatment in the 1990s, the ASI saw the introduction of newer items regarding addiction-related disorder and drug use, route of drug administration, antisocial personality disorder, trauma on top of the pre-existing framework of ASI-3, leading to the publication of ASI-5 in 1992.